Discontinued — last reported Q3 '23
Gilead Sciences Derivative assets increased by 342.9% to $31.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 342.9%, from $7.00M to $31.00M. Over 4 years (FY 2020 to FY 2024), Derivative assets shows an upward trend with a 80.7% CAGR.
Fluctuations reflect changes in market conditions and the firm's overall derivative hedging or trading strategy.
This represents the fair value of derivative contracts that are in a gain position for the firm. These instruments are u...
Standard for large financial institutions with significant capital markets operations.
fin_derivative_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $30.00M | $8.00M | $80.00M | $11.00M | $3.00M | $2.00M | $60.00M | $32.00M | $25.00M | $67.00M | $7.00M | $39.00M | $60.00M | $7.00M | $128.00M | $44.00M | $7.00M | $31.00M |
| QoQ Change | — | -73.3% | +900.0% | -86.3% | -72.7% | -33.3% | >999% | -46.7% | -21.9% | +168.0% | -89.6% | +457.1% | +53.8% | -88.3% | >999% | -65.6% | -84.1% | +342.9% |
| YoY Change | — | — | — | — | -90.0% | -75.0% | -25.0% | +190.9% | +733.3% | >999% | -88.3% | +21.9% | +140.0% | -89.6% | >999% | +12.8% | -88.3% | +342.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.